DOING MORE

Equipped with online and in-app ordering, Texas grocer named No. 1 for delivery

H-E-B is ringing up a new accolade. Photo courtesy

Widely praised for its response to the ongoing pandemic, Texas-based grocery chain H-E-B's cart has once again been filled with kudos.

In a study by market research and mystery shopping firm Ipsos, H-E-B ranked first for grocery delivery among U.S. retailers, with a 99 percent accuracy rate. At No. 2 in the grocery delivery category was Austin-based Whole Foods Market, which achieved a 95 percent accuracy rate.

For the study, mystery shoppers across the country rated various retailers on the quality of their buy-online-pickup-in-store (BOPIS), curbside, and delivery services. Ipsos conducted 150 mystery shops per retailer across these three categories.

"Use of BOPIS and curbside pickup has increased for 78 percent of shoppers since COVID-19 began, and 69 percent expect to continue using it at the same or higher levels after the pandemic subsides," Carlos Aragon, vice president of U.S. channel performance at Ipsos, says in an October 9 release. "As we continue to see the adoption and usage of these new digital offers rise and continue to stick, it is important that brands have the mechanism to ensure they deliver a seamless and safe customer experience for these new users."

To promote social distancing, H-E-B rolled out two-hour delivery in April, eliminating the need for customers to interact.

"With Texans relying on delivery now more than ever, it is our duty to support more of our communities across the state, as quickly as possible," Jag Bath, Favor's CEO and H-E-B's chief digital officer, said in an April release.

To accommodate two-hour delivery for H-E-B customers, Favor undertook a statewide expansion. The grocery chain rolled out its home delivery option in 2018, the same year that H-E-B bought Favor.

------

This article originally ran on CultureMap.

Trending News

Building Houston

 
 

Houston-based Soliton can use its audio pulse technology to erase scars, cellulite, and tattoos. Photo via soliton.com

Soliton, a Houston-based technology company, is using audio pulses to make waves in the med-aesthetic industry.

The company, which is licensed from the University of Texas on behalf of MD Anderson, announced that it had received FDA approval earlier this month for its novel and proprietary technology that can reduce the appearance of cellulite.

MIT engineer and doctor Christopher Capelli first developed the basis of the tool while he led the Office of Technology Based Ventures at M.D. Anderson.

Capelli uncovered that he could remove tattoos more effectively by treating the skin with up to 100 waves per second (about five to 10 times greater than other devices on the market), giving birth to the company's proprietary Rapid Acoustic Pulse (RAP) platform.

In 2012 he formed Soliton with co-founder and entrepreneur Walter Klemp, who also founded Houston-based Moleculin, and later brought on Brad Hauser as CEO. By 2019, the company had received FDA approval for using the technology for tattoo removal.

"The original indication was tattoo removal, which is what Chris envisioned," Hauser says. "The sound wave can increase in speed whenever it hits a stiffer or denser material. And tattoo ink is denser, stiffer than the surrounding dermis. That allows a shearing effect of the sound wave to disrupt that tattoo ink and help clear tattoos."

According to Hauser, the team then turned to a second application for the technology in the short-term improvement in the appearance of cellulite. With the use of the technology, patients can undergo a relatively pain-free, 40- to 60-minute non-invasive session with no recovery time.

Brad Hauser is the CEO of Soliton. Photo courtesy of Soliton

"It works similarly in the fibrous septa, which are the tethered bands that create the dimples and cellulite and the uneven skin. Those are stiffer than the surrounding fat cells in the subcutaneous tissue," Hauser says. "That allows the technology to disrupt those fibrous septa and loosen and release the dimples."

In 2021 the company plans to commercialize their product and get it into the hands of dermatologists, plastic surgeons, and other medical professionals for 25 key accounts—potentially including ones Houston—with a plan for a national rollout in 2022.

And they don't plan to stop there.

The company has already announced a partnership for a proof-of-concept study with the U.S. Navy in which Soliton will aim to use its technology to reduce the visibility of fibrotic scars, and more importantly work to increase mobility or playability of scars.

"Often the scar ends up causing restrictions in motion and discomfort with pressure of even clothing and certainly with sleeping," Hauser says. "We believe based on the reduction in volume and the increase in playability that we saw in our original proof-of-concept study that we will be able to bring benefits to these military patients."

Work on the study is slated to begin in the first half of this year.

In the meantime, the company is making headway with treatment of liver fibrosis, announcing just this week that it's pre-clinical study in animals demonstrated positive results and a reduction in effects by 42 percent seven days after the completion of carbon tetrachloride (CCL4) induction. The RAP technology was also named the best new technology by the Aesthetic Industry Association earlier this month.

"It's really targeting collagen fiber and fibroblasts on a cellular level" Hauser says. "Which we think has numerous potential uses in the future."

Trending News